Pharma Industry
Industry: Email Alert RSS FeedFluticasone cream generic gains tentative approval
Journal of Drugs in Dermatology, Sept-Oct, 2004
The FDA granted Atrix Laboratories tentative approval of the Abbreviated New Drug Application to market fluticasone propionate cream 0.05%. The new generic product is therapeutically bioequivalent to Cutivate, which is marketed by GlaxoSmithKline. The patent for Cutivate cream expired on May 14. 2004.
Most RecentPharma Articles
- Pfizer Will Fall Under Philippines Price Control; Company Ads Deny "Bribe"...
- Drug Ad Tax Deductions Saved After Rangel Committee Does U-Turn
- Novartis Q2: Generic Sales Decline Is a Warning for Pfizer, Sanofi and Abbott
- FDA Admits It Was Wrong to Ax Critic of Lilly's Effient
- "Bribe" or No, Pfizer May Get Its Way in Philippines
- More »
COPYRIGHT 2004 Journal of Drugs in Dermatology, Inc.
COPYRIGHT 2008 Gale, Cengage Learning
Brought to you by CBS MoneyWatch.com
- 10 Best Places to Retire
- Companies with the Best 401(k) Plans
- Most Important Document for Your Heirs? It's Not Your Will
- Video: Should You Expect to Retire Rich?
- Over 50? Here's How to Get (and Keep) a Great Job
Most Recent Health Articles
Most Recent Health Publications
Most Popular Health Articles
- Detox in 7 days: a detoux diet can help you shed up to 10 pounds and leave you feeling terrific. Our weeklong plan shows you how to lose the weight and keep it off - Cover story
- All about nightshades: explore the hidden hazards of your favorite food with macrobiotic nutritionist Lino Stanchich
- La anemia falciforme - causas y tratamiento
- The sour truth about apple cider vinegar - evaluation of therapeutic use
- Treat sinusitis naturally: breath easy and relieve sinus pressure with these remedies - Quick Fixes and Long-Term Solutions
Most Popular Health Publications
Content provided in partnership with
Sponsored by Merrill Lynch